Delivery Order SPE2DB20D2104-SPE2DB26FMBDC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,937.65 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with a completion date of August 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,855.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. The contract, awarded on October 31, 2025, with completion targeted for November 3, 2025, was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,040.00 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200 micrograms, 60-count units. This order, issued on November 3, 2025, with an ultimate completion date of December 2, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order as a child contract under its...
- The Defense Logistics Agency awarded a delivery order valued at $13,390.69 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination pharmaceutical product used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order,...
- The Defense Logistics Agency awarded a $10,547.87 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, due for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency has awarded a delivery order valued at $12,589.65 to AmerisourceBergen Drug Corp for the supply of TRELEGY ELLIPTA 100-62.5-25 (60-count units), a combination pulmonary medication. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $9,142.14 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory maintenance medication, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The place of performance is the vendor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.62 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of April 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a...
- The Defense Logistics Agency awarded a $29,315.47 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBDCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,902.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of October 29, 2025. This is a firm fixed-price, non-set-aside contract executed on October 28, 2025, with performance at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Logistics Agency's medical supply chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this prime indefinite delivery vehicle to supply a broad portfolio of medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contract awards demonstrate consistent capability in fulfilling competitive procurement requirements across multiple therapeutic domains, ranging from specialty medications to generic drugs, vaccines, and medical devices. This particular delivery order for TRELEGY ELLIPTA, a chronic obstructive pulmonary disease treatment, exemplifies the company's role as a critical vendor for federal military and veteran healthcare procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 10/28/25 |